Michelle is passionate about innovation in medicine and drug discovery, particularly in biologics and emerging treatment modalities. Most of all, Michelle is excited about the opportunity to partner with world-leading academics to bring their cutting edge research to life and build long-term positive impact for patients. Michelle started her career in the investment banking division at Goldman Sachs, in the Natural Resources team. She was also part of the investment team at BGH Capital and the Strategy & Operations team at FrankieOne. Michelle holds a Bachelor of Science, majoring in Neuroscience, from the University of Melbourne.